Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Sponsored diagnostic testing programs for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is an inherited heart muscle disorder characterized by gradual replacement of right ventricular myocardium with fibrofatty tissue. This process disrupts electrical signaling in the heart and increases the risk of ventricular arrhythmias, syncope, and sudden cardiac arrest. ARVC often presents in adolescence or early adulthood and is commonly linked to pathogenic variants in genes affecting cardiac desmosomes.

1 program found for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Programs

1 program
Invitae Unlock™

Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel

The Invitae Unlock™ Cardiomyopathy & Arrhythmia program offers sponsored genetic testing for U.S. patients with suspected inherited cardiomyopathy or arrhythmia. The comprehensive panel supports diagnostic clarification, risk assessment, and family variant identification. The test is billed to insurance first; when a claim is denied or the patient is uninsured, the program's sponsor covers the cost of testing. Testing must be ordered by a qualified healthcare provider.

Cardiology
ViewOrder
Performing lab
Invitae | Labcorp